Table 1 Basic characteristics of patients included in the meta-analysis.

From: Indirect meta-analysis comparing clinical outcomes of total cervical disc replacements with fusions for cervical degenerative disc disease

Author(year)

country, search duration

intervention (TDR/ACDF)

No. of patients (TDR/ACDF)

Mean age(years), female(%)

Number of cervical levels

FDA IDE trial

Follow up (months)

Anderson P. A.12

 

Bryan disc/ACDF using allograft and a titanium alloy plate and screw

242/221

 

1 level

YES

36

Burkus J. K.13

October 2002 to August 2004

Prestige disc/ACDF using allograft with a plate

276/265

43.59, 53.80

1 level

YES

84

Coric D.15

 

Kineflex C disc/ACDF using allograft and a plate

136/133

43.80, 59.11

1 level

YES

24

Delamarter R. B.17

US, August 2003 to October 2004

ProDisc-C/ACDF using allograft and a plate

103/106

42.81, 54.55

1 level

YES

48

Garrido B. J.18

 

Bryan disc/arthrodesis using allograft and a plate

21/26

41.83, 36.16

1 level

NO

48

Heller J. G.19

May 2002 to October 2004

Bryan disc/ACDF using allograft and a plate

242/221

44.54, 45.19

1 level

YES

24

Hisey M. S.20

US, April 2006 to March 2008

Mobi-C disc/ACDF using allograft and a plate(SLIM-LOCTM/Sofamor Danek ATLANTISTM/ATLANTISTM VISION anterior cervical plate system)

164/81

43.53, 53.47

1 level

YES

48

Mummaneni P.22

US, October 2002 to August 2004

Prestige disc/ACDF using allograft and a plate

276/265

43.59/53.80

1 level

YES

24

Murrey D. B.23

US, August 2003 to October 2004

Prodisc-C disc/ACDF using allograft with a plate

103/106

42.81, 54.55

1 level

YES

24

Murrey D. B.24

US, August 2003 to October 2004

Prodisc-C disc/ACDF using allograft with a plate

44/43

43.79, 44.83

1 level

YES

24

Riew K. D.25

US

Prestige ST disc/arthrodesis using allograft and a plate

59/52

44.62, 54.95

1 level

YES

24

 

US

Bryan disk/arthrodesis using allograft and a plate

47/41

44.45, 62.50

1 level

YES

24

Riina j.26

US

Prestige ST disc/ACDF using allograft with a plate

10/9

 

1 level

YES

24

Sasso R. C.27

 

Bryan disc/ACDF using allograft and ATLANTIS VISION plate

56/59

44.35, 46.09

1 level

YES

24

Upadhyaya C. D.28

US,

Prestige ST/ACDF using allograft and a plate

253/220

43.58, 53.79

1 level

YES

24

 

US,

Bryan Disc/ACDF using allograft and a plate

230/194

44.54, 51.94

1 level

YES

24

 

US,

Prodisc-C disc/ACDF using allograft and a plate

101/100

42.80, 54.55

1 level

YES

24

Zhang X.29

China, May 2004 to May 2006

Bryan Disc/ACDF using allograft and a plate

60/60

45.17, 44.17

1 level

YES

24

Zigler J. E.30

August 2003 to October 2004

ProDisc-C/ACDF using allograft and a plate

103/106

42.81, 54.55

1 level

YES

60

Davis R. J.16

US, April 2006 to March 2008

Mobi-C disc/ACDF using allograft and a plate

225/105

45.59, 52.12

2 level

YES

48

Coric D.14

 

Bryan disc/ACDF using an allograft and a plate

21/41

not detailed

1 or 2 level

YES

24

  

Kineflex C disc/ACDF using allograft and a plate

16/41

not detailed

1 or 2 level

YES

24

Jackson R. J.21

 

Mobi-C disc/ACDF using allograft and Slim-Loc Anterior Cervical Plate System/Sofamor Danek Atlantis or Atlantis Vision Anterior Cervical Plate System

179/81

not detailed

1 level

YES

60

  

Mobi-C disc/ACDF using allograft and Slim-Loc Anterior Cervical Plate System/Sofamor Danek Atlantis or Atlantis Vision Anterior Cervical Plate System

234/105

not detailed

2 level

YES

60

  1. FDA IDE trial: Food-and-Drug-Administration-regulated Investigational Device Exemption trial.